Zou Junjie, Yuan Dongping, Yang Jin, Yu Yun
First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Front Nutr. 2022 Feb 22;9:831485. doi: 10.3389/fnut.2022.831485. eCollection 2022.
At present, iliac vein compression syndrome (IVCS) plagues countless people, posing a significant economic and social burden. The progress of current IVCS-related research is slow owing to the limitations of animal models. In this study, we generated a mouse model of iliac vein stenosis (IVS) to monitor the effects of IVCS on venous function, such as increased vascular leakage, the expression of adhesion molecules, and elevated inflammation factors. Diosmin, a widely used clinical bioactive ingredient, was administered to confirm its therapeutic effects on the IVS mouse model. The results revealed that diosmin manifested therapeutic improvement in the IVS mouse model. In addition, we verified that the IVS mouse model is a stable and reproducible animal model for pathophysiological studies. High-purity diosmin can be beneficial to venous dysfunction and hence provides a more effective treatment option for venous diseases.
目前,髂静脉压迫综合征(IVCS)困扰着无数人,带来了巨大的经济和社会负担。由于动物模型的局限性,当前IVCS相关研究进展缓慢。在本研究中,我们构建了一个髂静脉狭窄(IVS)小鼠模型,以监测IVCS对静脉功能的影响,如血管渗漏增加、黏附分子表达以及炎症因子升高。地奥司明是一种广泛应用于临床的生物活性成分,我们通过给IVS小鼠模型给药来证实其治疗效果。结果显示,地奥司明在IVS小鼠模型中表现出治疗改善作用。此外,我们验证了IVS小鼠模型是一种用于病理生理研究的稳定且可重复的动物模型。高纯度地奥司明对静脉功能障碍有益,因此为静脉疾病提供了更有效的治疗选择。